Debbie Rigby rounds up the latest in research news Colchicine and the heart Clinical trials have demonstrated the benefits of colchicine in a range of cardiovascular conditions. Colchicine may reduce the risk of CV death, myocardial infarction, ischaemic stroke and ischaemia-driven revascularization by greater than 30%. The use of colchicine at doses of 0.5–1.0 mg daily
This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.